FDA Inspection 817419 — Fibrocell Technologies, Inc.
The FDA completed an inspection of Fibrocell Technologies, Inc. on October 12, 2012 in Exton, PA. The inspection was classified VAI (Voluntary Action Indicated — objectionable conditions were found but do not meet the threshold for regulatory action). Product area: Biologics.
Inspection Details
- Classification
- Voluntary Action Indicated (VAI) (VAI)
- End Date
- October 12, 2012
- Fiscal Year
- 2013
- Product Type
- Biologics
- Project Area
- Human Cellular, Tissue, and Gene Therapies
- Location
- Exton, PA (United States)